Israel Englander Novartis Ag Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $21.7 Million - $24.7 Million	-204,600 Reduced 97.1%	6,100 $701,000
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $3.79 Million - $4.39 Million	-40,900 Reduced 16.26%	210,700 $22.4 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $4.29 Million - $4.88 Million	45,000 Added 21.78%	251,600 $24.3 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $47.1 Million - $51.9 Million	-510,900 Reduced 71.21%	206,600 $20.9 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $18.7 Million - $21.2 Million	202,000 Added 39.19%	717,500 $72.4 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $4.76 Million - $5.52 Million	-59,500 Reduced 10.35%	515,500 $47.4 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $43.4 Million - $53.2 Million	575,000 New	575,000 $52.2 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.